BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6786787)

  • 1. [Difficulties in obtaining a reliable test for determining the virulence of a parasitic flagellate (Trichomonas vaginalis)].
    Delachambre D
    C R Seances Acad Sci III; 1981 Mar; 292(9):613-8. PubMed ID: 6786787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Virulence of Trichomonas vaginalis strains in relation to clinical forms of Trichomonas vaginitis].
    Małyszko E; Januszko T; Smorczewska-Czupryńska B; Ustymowicz-Farbiszewska J
    Wiad Parazytol; 1991; 37(2):219-23. PubMed ID: 1822038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pathogenicity of trichomonas vaginalis isolated from symptomatic & asymptomatic cases.
    Bhatt R; Deodhar L; Pandit D; Bhise R; Chatterjee DK
    J Postgrad Med; 1997; 43(3):68-70. PubMed ID: 10740726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pathogenicity of Trichomonas vaginalis isolated from symptomatic and asymptomatic cases.
    Bhatt R; Pandit D; Deodhar L; Bhise R; Chatterjee DK
    J Postgrad Med; 1993; 39(4):187-9. PubMed ID: 7996493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies against a 62 kDa proteinase of Trichomonas vaginalis decrease parasite cytoadherence to epithelial cells and confer protection in mice.
    Hernández H; Sariego I; Garber G; Delgado R; López O; Sarracent J
    Parasite Immunol; 2004 Mar; 26(3):119-25. PubMed ID: 15279622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the virulence of Trichomonas vaginalis strains by the study of their cytopathogenic effect on cultured cells].
    Brasseur P; Savel J
    C R Seances Soc Biol Fil; 1982; 176(6):849-60. PubMed ID: 6220793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of iron on the virulence of Trichomonas vaginalis.
    Ryu JS; Choi HK; Min DY; Ha SE; Ahn MH
    J Parasitol; 2001 Apr; 87(2):457-60. PubMed ID: 11318588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trichomonas vaginalis: characterization of a 39-kDa cysteine proteinase found in patient vaginal secretions.
    Hernández-Gutiérrez R; Avila-González L; Ortega-López J; Cruz-Talonia F; Gómez-Gutierrez G; Arroyo R
    Exp Parasitol; 2004; 107(3-4):125-35. PubMed ID: 15363938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic control of Trichomonas vaginalis infection. I. Resistance or susceptibility among different mouse strains.
    Landolfo S; Martinotti MG; Martinetto P; Forni G
    Boll Ist Sieroter Milan; 1979 Mar; 58(1):48-51. PubMed ID: 552834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemolytic activity of various strains and clones of Trichomonas vaginalis and Tritrichomonas suis].
    De Carli G; Brasseur P; Rott M; da Silva A; Wendorff A
    Rev Latinoam Microbiol; 1994; 36(3):207-11. PubMed ID: 7709097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of zymodeme patterns, virulence & drug sensitivity of Trichomonas vaginalis isolates from women.
    Vohra H; Sharma P; Sofi BA; Gupta I; Ganguly NK; Mahajan RC; Malla N
    Indian J Med Res; 1991 Jan; 93():37-9. PubMed ID: 2022400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response to Trichomonas vaginalis. I. Genetic regulation of IgE antibody response to T. vaginalis in mice.
    Yano A; Kaji R; Kojima S; Ovary Z
    Int Arch Allergy Appl Immunol; 1982; 67(4):310-4. PubMed ID: 6802768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenicity of Trichomonas vaginalis: cytopathologic and histopathologic changes of the cervical epithelium.
    Honigberg BM; Gupta PK; Spence MR; Frost JK; Kuczyńska K; Choromański L; Wartoń A
    Obstet Gynecol; 1984 Aug; 64(2):179-84. PubMed ID: 6377149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro comparative kinetics of adhesive and haemolytic potential of T. vaginalis isolates from symptomatic and asymptomatic females.
    Valadkhan Z; Sharma S; Harjai K; Gupta I; Malla N
    Indian J Pathol Microbiol; 2003 Oct; 46(4):693-9. PubMed ID: 15025385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of intravaginal microbicides to prevent acquisition of Trichomonas vaginalis infection in Lactobacillus-pretreated, estrogenized young mice.
    Lushbaugh WB; Blossom AC; Shah PH; Banga AK; Jaynes JM; Cleary JD; Finley RW
    Am J Trop Med Hyg; 2000; 63(5-6):284-9. PubMed ID: 11421379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal immunisation with a 62 kDa proteinase combined with cholera toxin or CpG adjuvant protects against Trichomonas vaginalis genital tract infections in mice.
    Hernández HM; Figueredo M; Garrido N; Sánchez L; Sarracent J
    Int J Parasitol; 2005 Nov; 35(13):1333-7. PubMed ID: 16202417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of immunoglobulin G, M, A and IgG subclass responses in experimental intravaginal trichomoniasis: prominence of IgG1 response.
    Yadav M; Gupta I; Malla N
    Parasite Immunol; 2005 Dec; 27(12):461-7. PubMed ID: 16255745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study on ultrastructural cytochemistry and pathogenic mechanism of Trichomonas vaginalis.
    Chen W; Cai H; Chen J; Zhong X; Chen L
    Chin Med J (Engl); 1996 Sep; 109(9):695-9. PubMed ID: 9275338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between size of Trichomonas vaginalis and pathogenicity.
    Mehta SH; Verma K
    Indian J Med Res; 1981 Aug; 74():231-5. PubMed ID: 6975756
    [No Abstract]   [Full Text] [Related]  

  • 20. Trichomonas vaginalis: in vitro phagocytosis of lactobacilli, vaginal epithelial cells, leukocytes, and erythrocytes.
    Rendón-Maldonado JG; Espinosa-Cantellano M; González-Robles A; Martínez-Palomo A
    Exp Parasitol; 1998 Jun; 89(2):241-50. PubMed ID: 9635448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.